AHA 2023 Insights: Erythropoietic Response After Intravenous Iron in HFrEF With or Without Background Treatment With SGLT2 Inhibitors

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

AHA 2023 Insights: Erythropoietic Response After Intravenous Iron in HFrEF With or Without Background Treatment With SGLT2 Inhibitors

By AHA 2023 Insights FEATURING Pedro Marques

168 views

November 21, 2023

0 Comments

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Primer on Diabetes Management

Feat. S. Inzucchi

11:37

ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich

11:25

ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster

18:43

ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo

26:01

Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo

27:14

MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz

17:44

Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24

Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan

13:07

Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

09:52

AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz

35:16

Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson

12:30

Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg

29:08

Scripps Health

Case Presentation: Complex PCI with IABP

Feat. R. Khedraki, T. Heywood, R. Mohan, A. Srivastava

30:04

Scripps Health

Menopause, Hormone Therapy, and the Heart: What the Evidence Shows

Feat. C. Shufelt

17:29

UCLA Health

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

Feat. D. Vucicevic

14:19

UChicago Medicine

S-QUAD Therapy and Beyond: HFpEF in 2024

Feat. M. Belkin

19:30

ACC 2022 Conference Coverage

Hot Topics in Heart Failure ACC.22

Feat. N. Ibrahim

34:18

Scripps Health

Cancer Survivorship: How To Monitor for Cardiac Disease Following Tr…

Feat. A. Kuo

84:17

Jefferson Health

2022 Heart Failure Guidelines Review

Feat. D. Haas

20:59

Mary E. Money

Login

Login

Join VuMedi

AHA 2023 Insights: Erythropoietic Response After Intravenous Iron in HFrEF With or Without Background Treatment With SGLT2 Inhibitors

Related Content